Dong-A St(170900)

Description: Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and annovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen for the treatment of gastritis; Suganon for diabetes treatment; Terizidone for active pulmonary and extra-pulmonary tuberculosis; and Zydena for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high technology medical devices, custom made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.

---

Keywords: Pharmaceutical Cancer Pharmaceutical Products Diabetes Chemotherapy Non Small Cell Lung Cancer Lung Cancer Ovarian Cancer Anemia Respiratory Diseases Erectile Dysfunction Non Small Cell Lung Carcinoma Infertility Mesothelioma Gastritis Markets Pharmaceutical Products Neoplasms Neutropenia Malignant Pleural Mesothelioma Chronic Renal Failure Diabetes Treatment Open Heart Surgery Erectile Dysfunction Treatment Small Cell Carcinoma

---

Home Page: www.donga-st.com

64 Cheonhodaero
Seoul,
South Korea
Phone: 82 2 920 8114

---

Officers

Exchange: KO

Country: KR

Currency: Korean Won (₩)